PL401345A1 - Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie - Google Patents

Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie

Info

Publication number
PL401345A1
PL401345A1 PL401345A PL40134512A PL401345A1 PL 401345 A1 PL401345 A1 PL 401345A1 PL 401345 A PL401345 A PL 401345A PL 40134512 A PL40134512 A PL 40134512A PL 401345 A1 PL401345 A1 PL 401345A1
Authority
PL
Poland
Prior art keywords
camptothecin derivatives
preparation
general formula
synthesis
iii
Prior art date
Application number
PL401345A
Other languages
English (en)
Other versions
PL235836B1 (pl
Inventor
Lech Kozerski
Robert Kawęcki
Beata Naumczuk
Karolina Hyz
Wojciech Bocian
Jerzy Sitkowski
Elżbieta Bednarek
Katarzyna Wiktorska
Katarzyna Lubelska
Original Assignee
Instytut Chemii Organicznej Polskiej Akademii Nauk
Narodowy Instytut Leków
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Organicznej Polskiej Akademii Nauk, Narodowy Instytut Leków filed Critical Instytut Chemii Organicznej Polskiej Akademii Nauk
Priority to PL401345A priority Critical patent/PL235836B1/pl
Priority to PL13824167T priority patent/PL2912039T3/pl
Priority to EP13824167.4A priority patent/EP2912039B1/en
Priority to PCT/IB2013/059668 priority patent/WO2014064654A1/en
Priority to US14/432,553 priority patent/US9682992B2/en
Publication of PL401345A1 publication Critical patent/PL401345A1/pl
Publication of PL235836B1 publication Critical patent/PL235836B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Przedmiotem wynalazku są rozpuszczalne w wodzie pochodne kamptotecyny o wzorze ogólnym (I), ich synteza, związki pośrednie o wzorze ogólnym (II) i (III) oraz ich zastosowanie do wytwarzania leków przeciwnowotworowych.
PL401345A 2012-10-25 2012-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie PL235836B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL401345A PL235836B1 (pl) 2012-10-25 2012-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie
PL13824167T PL2912039T3 (pl) 2012-10-25 2013-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie
EP13824167.4A EP2912039B1 (en) 2012-10-25 2013-10-25 Derivatives of camptothecin, a method of producing them and their use
PCT/IB2013/059668 WO2014064654A1 (en) 2012-10-25 2013-10-25 Derivatives of camptothecin, a method of producing them and their use
US14/432,553 US9682992B2 (en) 2012-10-25 2013-10-25 Derivatives of camptothecin, a method of producing them and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL401345A PL235836B1 (pl) 2012-10-25 2012-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie

Publications (2)

Publication Number Publication Date
PL401345A1 true PL401345A1 (pl) 2014-04-28
PL235836B1 PL235836B1 (pl) 2020-11-02

Family

ID=50001041

Family Applications (2)

Application Number Title Priority Date Filing Date
PL401345A PL235836B1 (pl) 2012-10-25 2012-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie
PL13824167T PL2912039T3 (pl) 2012-10-25 2013-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13824167T PL2912039T3 (pl) 2012-10-25 2013-10-25 Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie

Country Status (4)

Country Link
US (1) US9682992B2 (pl)
EP (1) EP2912039B1 (pl)
PL (2) PL235836B1 (pl)
WO (1) WO2014064654A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109206432A (zh) * 2017-06-30 2019-01-15 江苏汉邦科技有限公司 一种喜树碱单体的制备方法
LU102067B1 (en) 2020-09-17 2022-03-18 Narodowy Inst Lekow 7-Ethyl-10-hydroxycamptothecin derivatives for use in the treatment of cancer
WO2025255212A1 (en) * 2024-06-07 2025-12-11 Codeable Therapeutics, Incorporated Topoisomerase inhibitors, antibody-drug conjugates comprising them, and methods of their use
CN119912467B (zh) * 2025-01-22 2025-10-24 上海科技大学 一种氘代喜树碱衍生物及其制备方法与用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP2684104B2 (ja) * 1990-02-09 1997-12-03 株式会社ヤクルト本社 新規なカンプトテシン誘導体
ITMI20061474A1 (it) 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale
CN101133813B (zh) 2007-09-17 2010-06-09 国投中鲁果汁股份有限公司 一种浓缩黄瓜清汁及生产方法
ES2371171B1 (es) 2010-06-08 2012-11-16 Consejo Superior De Investigaciones Científicas (Csic) Derivados de camptotecina como agentes antitumorales.
CN103113381B (zh) * 2013-02-26 2014-12-10 大连理工大学 系列水溶性羟基喜树碱环烷胺醇衍生物及其制法与用途

Also Published As

Publication number Publication date
EP2912039B1 (en) 2017-07-12
US20150266888A1 (en) 2015-09-24
PL2912039T3 (pl) 2018-01-31
EP2912039A1 (en) 2015-09-02
PL235836B1 (pl) 2020-11-02
WO2014064654A1 (en) 2014-05-01
US9682992B2 (en) 2017-06-20

Similar Documents

Publication Publication Date Title
CY1123649T1 (el) Παραγωγα ιμιδαζολινης, μεθοδοι παρασκευης αυτων και εφαρμογες αυτων στην ιατρικη
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
JO3419B1 (ar) مركبات بيريدوبيرازين مضادة للسرطان من خلال تثبيط إنزيمات كيناز fgfr
PH12015501289B1 (en) Novel benzimidazole derivatives as ep4 antagonists
EA201491447A1 (ru) Ендиины, их конъюгаты и способы их получения и применения
NZ710729A (en) Amatoxin derivatives
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
EA201390203A1 (ru) Способы получения тубулизинов
CY1119953T1 (el) Yποκατεστημενες πυριδοπυραζινες ως προτυποι syk ανοστολεις
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
IN2015DN03998A (pl)
HK1214128A1 (zh) 癌症的治療
CO7170173A2 (es) Derivados de carbamato/urea
MX2016015856A (es) Derivados de naftiridinadiona.
PL401345A1 (pl) Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie
CY1119871T1 (el) Στερεη μορφη αλατος της aλφa-6-mpeg6-o- υδροξυκωδονης ως αγωνιστες οπιοειδων και χρησεις αυτων
WO2014172363A3 (en) Combretastatin analogs
EA201590372A1 (ru) Бициклические гетероарилциклоалкилдиаминовые производные в качестве ингибиторов тирозинкиназ селезенки (syk)
MX2018004696A (es) Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos.
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
EP3126356A4 (en) Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synthesis and uses thereof
MX365192B (es) Derivados de bendamustina y compuestos relacionados, y uso medico de los mismos para la terapia de cancer.
EA201590752A1 (ru) Препараты производных пиримидиндиона
MX2013003859A (es) Polimorfos de picropodofilina b o c para su uso en la terapia del cancer.
PH12018500014A1 (en) Total synthesis of shishijimicin a and analogs thereof